MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Macrophage Activation Syndrome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Macrophage Activation < Macrophage Activation Syndrome < Macrophage Migration-Inhibitory Factors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000381 (2019) Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie]Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
000383 (2019) Tomo Nozawa [Japon] ; Kenichi Nishimura [Japon] ; Asami Ohara [Japon] ; Ryoki Hara [Japon] ; Shuichi Ito [Japon]Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
000691 (2018) Naoto Sakumura [Japon] ; Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
000856 (2018) Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis]Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
000B18 (2017) Masaki Shimizu [Japon] ; Yasuo Nakagishi [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Akihiro Yachie [Japon]Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
000C62 (2016) A. Deroux [France] ; F. Andry [France] ; L. Bouillet [France][Macrophage activation syndrome secondary to tocilizumab: Myth or reality?].
000E15 (2016) Alexei A. Grom [États-Unis] ; Annacarin Horne [Suède] ; Fabrizio De Benedetti [Italie]Macrophage activation syndrome in the era of biologic therapy.
000E31 (2016) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Immunotherapeutic implications of IL-6 blockade for cytokine storm.
000F24 (2016) Sulaiman M. Al-Mayouf [Arabie saoudite] ; Abdullatif Alenazi [Arabie saoudite] ; Hind Aljasser [Arabie saoudite]Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
000F45 (2016) Mark Wunderlich ; Courtney Stockman ; Mahima Devarajan ; Navin Ravishankar ; Christina Sexton ; Ashish R. Kumar [États-Unis] ; Benjamin Mizukawa ; James C. MulloyA xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.
001068 (2015) Marie Leroy [France] ; Guillaume Coiffier [France] ; Charlotte Pronier [France] ; Louise Triquet [France] ; Aleth Perdriger [France] ; Pascal Guggenbuhl [France]Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis.
001069 (2015) Shumpei Yokota [Japon] ; Yasuhiko Itoh ; Tomohiro Morio ; Naokata Sumitomo ; Kaori Daimaru ; Seiji MinotaMacrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
001095 (2015) Loredana Cifaldi [Italie] ; Giusi Prencipe [Italie] ; Ivan Caiello [Italie] ; Claudia Bracaglia [Italie] ; Franco Locatelli [Italie] ; Fabrizio De Benedetti [Italie] ; Raffaele Strippoli [Italie]Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
001153 (2015) Normi Bruck [Allemagne] ; Anja Schnabel [Allemagne] ; Christian M. Hedrich [Allemagne]Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches.
001308 (2014) Leila Souabni [Tunisie] ; Leila Dridi [Tunisie] ; Kawther Ben Abdelghani [Tunisie] ; Selma Kassab [Tunisie] ; Selma Chekili [Tunisie] ; Ahmed Laater [Tunisie] ; Leith Zakraoui [Tunisie]Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still's disease.
001358 (2014) Eimear Savage [Royaume-Uni] ; Tasheen Wazir [Royaume-Uni] ; Mary Drake [Royaume-Uni] ; Robert Cuthbert [Royaume-Uni] ; Gary Wright [Royaume-Uni]Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
001532 (2013) Christopher Banse [France] ; Olivier Vittecoq ; Ygal Benhamou ; Maud Gauthier-Prieur ; Thierry Lequerré ; Hervé LévesqueReactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
001579 (2013) Gaia Vannucci [Oman] ; Luca Cantarini ; Teresa Giani ; Edoardo Marrani ; Davide Moretti ; Ilaria Pagnini ; Gabriele Simonini ; Rolando CimazGlucocorticoids in the management of systemic juvenile idiopathic arthritis.
001936 (2011) Masafumi Kobayashi [Japon] ; Yuko Takahashi ; Hiroyuki Yamashita ; Hiroshi Kaneko ; Akio MimoriBenefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
001D17 (????) Andreas Plate ; Florence Vallelian ; Gregor Herfs

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Macrophage Activation Syndrome" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Macrophage Activation Syndrome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Macrophage Activation Syndrome
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021